IPAM
GILD icon

ICICI Prudential Asset Management’s Gilead Sciences GILD Stock Holding History

ICICI Prudential Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.59M Sell
20,532
-41
-0.2% -$5.4K 0.28% 94
2026
Q1 		$2.87M Buy
20,573
+662
+3% +$92.7K 0.34% 82
2025
Q4 		$2.44M Buy
19,911
+856
+4% +$104K 0.29% 91
2025
Q3 		$2.12M Buy
19,055
+3,466
+22% +$394K 0.22% 92
2025
Q2 		$1.73M Sell
15,589
-36,809
-70% -$3.92M 0.22% 88
2025
Q1 		$5.87M Sell
52,398
-77,556
-60% -$8M 0.76% 40
2024
Q4 		$12M Sell
129,954
-23
-0% -$2.07K 1.32% 12
2024
Q3 		$10.9M Sell
129,977
-11,934
-8% -$911K 1.15% 16
2024
Q2 		$9.74M Buy
141,911
+6,783
+5% +$453K 1.15% 14
2024
Q1 		$9.9M Buy
135,128
+27,355
+25% +$2.1M 1.12% 19
2023
Q4 		$8.73M Sell
107,773
-14,514
-12% -$1.13M 1.01% 29
2023
Q3 		$9.16M Buy
122,287
+21,106
+21% +$1.62M 1.2% 15
2023
Q2 		$7.8M Buy
101,181
+75,096
+288% +$5.99M 0.99% 29
2023
Q1 		$2.16M Buy
26,085
+19,786
+314% +$1.64M 0.32% 62
2022
Q4 		$541K Sell
6,299
-106,181
-94% -$8.41M 0.08% 78
2022
Q3 		$6.94M Buy
112,480
+862
+0.8% +$54.4K 1.08% 21
2022
Q2 		$6.97M Buy
111,618
+136
+0.1% +$8.42K 1.27% 16
2022
Q1 		$6.65M Buy
111,482
+9,509
+9% +$608K 0.89% 30
2021
Q4 		$7.4M Buy
101,973
+3,096
+3% +$213K 0.91% 22
2021
Q3 		$6.91M Hold
98,877
– – 1.17% 14
2021
Q2 		$6.81M Buy
98,877
+28,563
+41% +$1.91M 2.57% 6
2021
Q1 		$4.61M Buy
70,314
+5,534
+9% +$357K 2.36% 17
2020
Q4 		$3.77M Buy
+64,780
New +$3.91M 2.57% 17
2017
Q3 		$640K Hold
7,900
– – 3.01% 3
2017
Q2 		$601K Hold
7,900
– – 2.64% 6
2017
Q1 		$537K Hold
7,900
– – 1.49% 23
2016
Q4 		$566K Buy
+7,900
New +$587K 0.6% 16

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ICICI Prudential Asset Management's GILD Position: Q2 2026 in Review

ICICI Prudential Asset Management reduced its Gilead Sciences (GILD) stake by 0.2% in Q2 2026, selling an estimated $5.4K and leaving 20,532 shares worth $2.59M. The position accounts for 0.28% of the portfolio, ranked #94.

ICICI Prudential Asset Management first reported a position in GILD in Q4 2016 and has held it in 27 quarters since. The position peaked at $12M in Q4 2024. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • ICICI Prudential Asset Management held 20,532 shares of Gilead Sciences worth $2.59M as of Q2 2026.
  • ICICI Prudential Asset Management sold 41 Gilead Sciences shares in Q2 2026, an estimated $5.4K.
  • Gilead Sciences made up 0.28% of ICICI Prudential Asset Management's portfolio in Q2 2026, its #94 holding.
  • ICICI Prudential Asset Management first reported a position in Gilead Sciences in Q4 2016 and has held it in 27 quarters since.
  • ICICI Prudential Asset Management's Gilead Sciences position peaked at $12M in Q4 2024.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on ICICI Prudential Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.